2023
DOI: 10.1016/j.meomic.2023.100022
|View full text |Cite
|
Sign up to set email alerts
|

Molecular diagnostics and potential therapeutic options for mycobacterium tuberculosis: Where we stand

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 124 publications
0
2
0
Order By: Relevance
“…Significant level of co-resistance (P<0.001) was also seen between INH and five other drugs (EMB, PZA, STR, LFX and MOX) ( Table 4 ). Co-resistance between INH and other drugs may possibly be due to the high spontaneous mutation rate of INH or due to inhA as such mutations have been previously implicated in co-resistance to INH and PTO as they have the same target, InhA ( 35 , 36 ). The accumulation of drug resistance mutations occurs in a cumulative manner, so the presence of co-resistant strains implies that these strains have been subject to multiple therapies over the lifetime of the strain lineage.…”
Section: Discussionmentioning
confidence: 99%
“…Significant level of co-resistance (P<0.001) was also seen between INH and five other drugs (EMB, PZA, STR, LFX and MOX) ( Table 4 ). Co-resistance between INH and other drugs may possibly be due to the high spontaneous mutation rate of INH or due to inhA as such mutations have been previously implicated in co-resistance to INH and PTO as they have the same target, InhA ( 35 , 36 ). The accumulation of drug resistance mutations occurs in a cumulative manner, so the presence of co-resistant strains implies that these strains have been subject to multiple therapies over the lifetime of the strain lineage.…”
Section: Discussionmentioning
confidence: 99%
“…In conclusion, the integration of personalized treatment planning into nursing care, through customized therapeutic approaches, the monitoring of molecular biomarkers, and the central role of nursing in personalized medicine, represents a significant advance in healthcare. This approach necessitates a combination of sophisticated genetic analysis, continuous monitoring and adjustment of treatment plans based on quantitative data, and a skilled nursing workforce capable of bridging the gap between molecular biology and patient care [5].…”
Section: The Role Of Nursing In Personalized Carementioning
confidence: 99%
“…Several new antibiotics (bedaquiline, delamanid, and pretomanid) have received approval for the treatment of M. tuberculosis MDR infections [ 37 , 47 ], but unfortunately, resistance has already merged with these new compounds [ 48 , 49 ]. Derivatives of existing anti-tuberculosis medications, such as ethambutol, and repurposed drugs, such as linezolid and clofazimine, have also been proposed but have been threatened by the quick emergence of resistance [ 43 , 49 , 50 , 51 ].…”
Section: Introductionmentioning
confidence: 99%